Discovery of 4-(4-(3-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazole-2-yl)isoxazol-5-yl)phenyl)morpholine as a novel c-Myc inhibitor against lung cancer in vitro and in vivo.

MLA

Gao, Jian, et al. “Discovery of 4-(4-(3-(1-(2-(Piperidin-1-Yl)Ethyl)-1H-Benzo[d]Imidazole-2-Yl)Isoxazol-5-Yl)Phenyl)Morpholine as a Novel c-Myc Inhibitor against Lung Cancer in Vitro and in Vivo.” European Journal of Medicinal Chemistry, vol. 281, Jan. 2025, p. 117023. EBSCOhost, https://doi.org/10.1016/j.ejmech.2024.117023.

APA

Gao, J., Yin, J., Li, S., Jia, P., Hong, R., Chen, J., Qu, X., Zhang, Z., Li, M., & Zhao, H. (2025). Discovery of 4-(4-(3-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazole-2-yl)isoxazol-5-yl)phenyl)morpholine as a novel c-Myc inhibitor against lung cancer in vitro and in vivo. European Journal of Medicinal Chemistry, 281, 117023. https://doi.org/10.1016/j.ejmech.2024.117023

Chicago

Gao, Jian, Jiacheng Yin, Shihao Li, Pingting Jia, Renjie Hong, Jiahui Chen, Xinxin Qu, Zihui Zhang, Mengting Li, and Hui Zhao. 2025. “Discovery of 4-(4-(3-(1-(2-(Piperidin-1-Yl)Ethyl)-1H-Benzo[d]Imidazole-2-Yl)Isoxazol-5-Yl)Phenyl)Morpholine as a Novel c-Myc Inhibitor against Lung Cancer in Vitro and in Vivo.” European Journal of Medicinal Chemistry 281 (January): 117023. doi:10.1016/j.ejmech.2024.117023.